Literature DB >> 27515285

Antiamyloidogenic Effects of Ellagic Acid on Human Serum Albumin Fibril Formation Induced by Potassium Sorbate and Glucose.

F Taghavi1,2, M Habibi-Rezaei3, M Bohlooli1,4, M Farhadi5, M Goodarzi1, S Movaghati1, P Maghami1, C Taghibiglou6, M Amanlou7, T Haertlé8,9, A A Moosavi-Movahedi1,10.   

Abstract

Oxidative stress has the main role in protein conformational changes and consequent direct involvement in different kind of diseases. Potassium sorbate as a widespread industrial preservative and glucose are two important oxidants that can be involved in oxidative stress. In this study the effect of ellagic acid as a phenolic antioxidant on amyloid fibril formation of human serum albumin upon incubation of potassium sorbate and glucose was studied using thioflavin T assay, surface tension, atomic force microscopy, Amadori product, and carbonyl content assays. The thioflavin T assay and atomic force microscopy micrographs demonstrated the antiamyloidogenic effect of ellagic acid on the human serum albumin fibril formation. This antioxidant also had the repair effect on surface tension of the modified human serum albumin (amyloid intermediates), which was destructed, caused by potassium sorbate and glucose. This mechanism takes place because of potent carbonyl stress suppression effect of ellagic acid, which was strengthening by potassium sorbate in the presence and absence of glucose.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HSA; ellagic acid; glucose; glycation; oxidative stress; potassium sorbate; reactive carbonyl species

Mesh:

Substances:

Year:  2016        PMID: 27515285     DOI: 10.1002/jmr.2560

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  1 in total

1.  Ellagic acid ameliorates learning and memory impairment in APP/PS1 transgenic mice via inhibition of β-amyloid production and tau hyperphosphorylation.

Authors:  Lili Zhong; Hong Liu; Weijia Zhang; Xu Liu; Bo Jiang; Hongxin Fei; Zhongren Sun
Journal:  Exp Ther Med       Date:  2018-10-15       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.